Systemic reduced-dose alteplase for diffuse pulmonary thrombi in a COVID-19 patient.

Autor: Colkesen Y; Department of Cardiology Erdem Hospital Istanbul Turkey.
Jazyk: angličtina
Zdroj: Clinical case reports [Clin Case Rep] 2023 Mar 15; Vol. 11 (3), pp. e7116. Date of Electronic Publication: 2023 Mar 15 (Print Publication: 2023).
DOI: 10.1002/ccr3.7116
Abstrakt: Pulmonary embolism has a high frequency in COVID-19 patients admitted to the intensive care unit. Low level of fibrinolysis is one of the asserted contributors to a prothrombotic state in COVID-19. Thrombotic coagulopathy is mostly encountered as diffuse pulmonary thrombi. Diffuse pulmonary microemboli was treated successfully with reduced dose thrombolysis.
Competing Interests: None.
(© 2023 The Author. Clinical Case Reports published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje